V. Bryan Lawlis

Insider Reports History

Entity
Individual
Signature
/s/ Scott A. Samuels for V. Bryan Lawlis
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by V. Bryan Lawlis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BIOMARIN PHARMACEUTICAL INC Director Common Stock 33.1K $3.19M $96.38 May 23, 2023 Direct
GERON CORP Director Common Stock 0 $0 $3.75 May 15, 2024 Direct
Aeglea BioTherapeutics, Inc. Director Director Stock Option (right to buy) 43K Jun 7, 2022 Direct
GERON CORP Director Stock Option (right to buy) 0 May 15, 2024 Direct

Insider Reports Filed by V. Bryan Lawlis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GERN GERON CORP May 15, 2024 3 -$63.4K 4 May 17, 2024 Director
GERN GERON CORP May 9, 2024 1 $0 4 May 10, 2024 Director
GERN GERON CORP May 31, 2023 1 $0 4 Jun 2, 2023 Director
BMRN BIOMARIN PHARMACEUTICAL INC May 23, 2023 1 $0 4 May 24, 2023 Director
GERN GERON CORP May 11, 2023 3 -$66.5K 4 May 11, 2023 Director
BMRN BIOMARIN PHARMACEUTICAL INC Apr 3, 2023 3 -$249K 4 Apr 4, 2023 Director
AGLE Aeglea BioTherapeutics, Inc. Jun 7, 2022 1 $0 4 Jun 9, 2022 Director
BMRN BIOMARIN PHARMACEUTICAL INC May 24, 2022 1 $0 4 May 26, 2022 Director
GERN GERON CORP May 10, 2022 1 $0 4 May 11, 2022 Director
BMRN BIOMARIN PHARMACEUTICAL INC Apr 14, 2022 3 -$196K 4 Apr 18, 2022 Director
BMRN BIOMARIN PHARMACEUTICAL INC Jan 14, 2022 3 -$213K 4 Jan 19, 2022 Director
AGLE Aeglea BioTherapeutics, Inc. Jun 8, 2021 1 $0 4 Jun 9, 2021 Director
BMRN BIOMARIN PHARMACEUTICAL INC May 25, 2021 1 $0 4 May 27, 2021 Director
GERN GERON CORP May 11, 2021 1 $0 4 May 13, 2021 Director